SeaStar Medical Holding Corporation filed a Form 8-K on November 12, 2026, reporting that on November 11, 2026, it issued a press release and hosted a webcast covering its financial condition and results of operations for the three and nine months ended September 30, 2026.

Key Highlights

  • Reporting period: Financial results cover the three and nine months ended September 30, 2026, according to the filing.
  • Press release: The company issued a press release on November 11, 2026, furnished as Exhibit 99.1.
  • Conference call: A webcast was hosted on November 11, 2026; a transcript is furnished as Exhibit 99.2.
  • Archived webcast: The company disclosed that an archived webcast will be available for three months after the event.
  • Furnished, not filed: The filing states the information is "furnished" and not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
  • Signed by: The report was signed by Eric Schlorff, Chief Executive Officer, on November 12, 2026.

SeaStar Medical Discloses Q3 2026 Earnings Materials via 8-K

SeaStar Medical Holding Corporation (NASDAQ:ICU), a Delaware-incorporated company headquartered at 3513 Brighton Blvd, Suite 410, Denver, Colorado 80216, filed a current report on Form 8-K dated November 12, 2026. The filing is made under Item 2.02, Results of Operations and Financial Condition, and relates to events occurring on November 11, 2026.

According to the filing, the company issued a press release on November 11, 2026, announcing its financial condition and results of operations for the three and nine months ended September 30, 2026. That press release is attached as Exhibit 99.1. The company also hosted a webcast on the same date to discuss financial and operating results for the quarter ended September 30, 2026, and a transcript of that conference call is furnished as Exhibit 99.2. The filing notes that an archived webcast will be available for three months after the event at a web address provided in a separate call notice press release.

The filing specifies that all information contained within it, including the exhibits, is deemed "furnished" and not "filed" under Section 18 of the Securities Exchange Act of 1934, as amended, and is not subject to the liabilities of that section. The filing also contains forward-looking statements, which the company characterizes as subject to risks, uncertainties, and assumptions, noting that "actual results of performance" may be "materially different" from those expressed or implied by such statements.

What Was Disclosed

SeaStar Medical Holding Corporation furnished its Q3 2026 earnings press release and conference call transcript via an 8-K filed November 12, 2026, covering the three and nine months ended September 30, 2026. No detailed financial figures were included in the 8-K body itself.